Alpha 2.0
Login Register
» Authors » Ulrike Denzer

Ulrike Denzer

Explore the profile of Ulrike Denzer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 236
Followers 0
Related Specialties
Gastroenterology
Radiology
General Medicine
Top 10 Co-Authors
Ansgar W Lohse
Siegbert Faiss
Ralf Jakobs
Peter R Galle
Thomas Frieling
Ulrich Tappe
Ludger Leifeld
Henrike Lenzen
Julia Mayerle
Alanna Ebigbo
Published In
Z Gastroenterol
Am J Gastroenterol
J Hepatol
Gastrointest Endosc
J Clin Virol
Affiliations
Soon will be listed here.
Recent Articles
1.
Endoscopic Submucosal Dissection for Early Gastric Cancer Exceeding Expanded Criteria-Long-Term Outcomes from the German ESD Registry
Riedl K, Probst A, Ebigbo A, Steinbruck I, Allgaier H, Albers D, et al.
J Clin Med . 2024 Sep; 13(18). PMID: 39337025
Endoscopic submucosal dissection (ESD) has become a standard treatment for early gastric cancer (EGC), often fulfilling guideline criteria (GC) or expanded criteria (EC). When lesions exceed the EC, surgical resection...
2.
[New methods for colorectal cancer screening]
Denzer U, Nitschmann S
Inn Med (Heidelb) . 2024 Sep; 65(10):1048-1050. PMID: 39225805
No abstract available.
3.
[Influence of specialization on primary success and complication rate in ERCP. Proposal to improve the quality of ERCP]
Leifeld L, Jakobs R, Frieling T, Denzer U, Faiss S, Lenzen H, et al.
Z Gastroenterol . 2024 Aug; 62(8):1224-1228. PMID: 39111334
Endoscopic retrograde cholangiopancreatography [ERCP] is a complex procedure with a flat learning curve. It is associated with the risk of serious complications such as pancreatitis, bleeding, cholangitis and perforation. Endosonography...
4.
Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) - a multicenter, randomized, controlled, open-label investigator-initiated trial
Schmidt C, Zapf A, Ozga A, Canbay A, Denzer U, De Toni E, et al.
BMC Cancer . 2024 Aug; 24(1):931. PMID: 39090600
Background: Despite the recent advances in cancer treatment, the therapeutic options for patients with biliary tract cancer are still very limited and the prognosis very poor. More than 50% of...
5.
Pancreatic cancer screening is effective in individuals at risk with predisposing germline gene variants, but not in gene variant-negative familial pancreatic cancer families
Maurer E, Lehman B, Matthai E, Denzer U, Figiel J, Jesinghaus M, et al.
United European Gastroenterol J . 2024 Jul; 12(9):1211-1221. PMID: 39031472
Objective: To evaluate the diagnostic yield of pancreatic cancer screening in individuals at risk (IAR) from familial pancreatic cancer (FPC) families with respect to the presence or absence of pathogenic...
6.
Endoscopic submucosal dissection versus endoscopic mucosal resection for the treatment of rectal lesions involving the dentate line
Kouladouros K, Jakobs J, Stathopoulos P, Kahler G, Belle S, Denzer U
Surg Endosc . 2024 Jun; 38(8):4485-4495. PMID: 38914887
Background: The ideal treatment of epithelial neoplastic rectal lesions involving the dentate line is a controversial issue. Piecemeal endoscopic mucosal resection (EMR) is the most commonly used resection technique, but...
7.
Oncologic Decision after Endoscopic Resection of Gastrointestinal Malignancies: Interdisciplinary Discussion
Kouladouros K, Bourke M, Denzer U, Ebigbo A, Pioche M, Schmidt A, et al.
Visc Med . 2024 Jun; 40(3):156-160. PMID: 38873625
No abstract available.
8.
Endoscopic submucosal dissection for early esophageal adenocarcinoma: low rates of metastases in mucosal cancers with poor differentiation
Probst A, Kappler F, Ebigbo A, Albers D, Faiss S, Steinbruck I, et al.
Gastrointest Endosc . 2024 Mar; 100(4):626-636. PMID: 38479623
Background And Aims: Endoscopic resection is accepted as standard treatment for intramucosal esophageal adenocarcinoma (EAC) that is well or moderately differentiated. Poor differentiation (PD) is judged as a risk factor...
9.
[Correction: Structural, procedural, and personnel requirements for cross-sectoral provision of endoscopic gastroenterological procedures]
Leifeld L, Denzer U, Frieling T, Jakobs R, Faiss S, Lenzen H, et al.
Z Gastroenterol . 2023 Aug; 61(7):e627. PMID: 37625458
No abstract available.
10.
[Structural, procedural, and personnel requirements for cross-sectoral provision of endoscopic gastroenterological procedures]
Leifeld L, Denzer U, Frieling T, Jakobs R, Faiss S, Lenzen H, et al.
Z Gastroenterol . 2023 Jul; 61(7):799-809. PMID: 37494075
Gastroenterology has made crucial advances in diagnostic and interventional endoscopic procedures, opening up improvements in the treatment of many patients. Thus, organ-preserving treatments are increasingly being made possible, replacing more...